Stocktoria
CORCEPT THERAPEUTICS INC CORT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-04-15
CORCEPT THERAPEUTICS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 5.9% | 20.3% | 22.2% | 28.0% | 34.0% |
| Net margin | 13.1% | 20.9% | 22.0% | 25.2% | 30.7% |
| FCF margin | 18.6% | 29.1% | 26.2% | 29.8% | 45.7% |
| Return on assets | 11.9% | 16.8% | 17.1% | 17.4% | 26.6% |
| Return on equity | 15.4% | 20.8% | 20.9% | 20.2% | 29.9% |
| Current ratio | 2.92 | 3.35 | 4.39 | 6.89 | 5.60 |
| Revenue growth | 12.8% | 39.9% | 20.0% | 9.8% | 3.4% |
Source: SEC EDGAR filings · CIK 0001088856 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.